![Stephanie Okey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephanie Okey
Direktor/Vorstandsmitglied bei
PTC THERAPEUTICS, INC.
Vermögen: 394 083 $ am 31.08.2026
Profil
Ms. Stephanie S.
Okey is an Independent Director at Crinetics Pharmaceuticals, Inc. and an Independent Director at PTC Therapeutics, Inc. She is on the Board of Directors at Crinetics Pharmaceuticals, Inc. and PTC Therapeutics, Inc. Ms. Okey was previously employed as an Independent Director by Catalent, Inc., an Independent Director by Albireo Pharma, Inc., and a GM-Rare Disease Business Unit & Senior VP by Genzyme Corp.
She also served on the board at Orphazyme A/S and California Life Sciences Association.
She received her undergraduate degree from The Ohio State University and a graduate degree from Wright State University (Ohio).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.04.2026 | 5’667 ( 0.01% ) | 394 083 $ | 31.08.2026 |
Aktive Positionen von Stephanie Okey
| Unternehmen | Position | Beginn |
|---|---|---|
| PTC THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 18.12.2018 |
Ehemalige bekannte Positionen von Stephanie Okey
| Unternehmen | Position | Ende |
|---|---|---|
| CRINETICS PHARMACEUTICALS | Direktor/Vorstandsmitglied | 01.09.2026 |
| CATALENT, INC. | Direktor/Vorstandsmitglied | 18.12.2024 |
| ALBIREO PHARMA, INC. | Direktor/Vorstandsmitglied | 02.03.2023 |
| STRATEGIC PARTNERS A/S | Direktor/Vorstandsmitglied | 23.05.2022 |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Direktor/Vorstandsmitglied | 01.01.2016 |
Ausbildung von Stephanie Okey
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
89
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wright State University (Ohio)
 Wright State University (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Strategic Partners A/S
 Strategic Partners A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic treatment of of diseases caused by defects in the function and metabolism of proteins | Health Technology |
Catalent, Inc.
 Catalent, Inc. Pharmaceuticals: MajorHealth Technology Provides delivery technologies and development solutions | Health Technology |
Crinetics Pharmaceuticals, Inc.
 Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
